Bloomberg New Economy Conversations with Andrew Browne
Vaccine Miracles and the New Promise of Science
March 23, 10 am ET
Big Pharma, allied with cutting-edge biotech companies and supported by governments, just delivered a modern scientific miracle: not one but multiple vaccines against Covid-19 — and in record time. This was a moonshot compressed into a few months, accelerated by unprecedented collaboration between rival pharma giants and featuring large numbers of female scientists — many of them immigrants. The victory could help incentivize big pharma to produce more medicines for all rather than pricey remedies for niche diseases. What lessons can be learned from what is arguably the biggest scientific breakthrough of the 21st century? Can successful public-private partnerships be replicated to accelerate other moonshot initiatives?
Watch the replay below and click here to view the transcript
Featuring
Janice Chen
Co-founder and CTO Mammoth Biosciences
Katalin Karikó
Senior Vice President BioNTech
Rodrigo Yáñez
Undersecretary of International Economic Relations Chile
Andrew Browne
Editorial Director Bloomberg New EconomyPast conversations
The Big
“Bounce-Back”
As the Covid-19 vaccine rollout gathers pace, the stage is set for a global economic bounce-back in the second half of 2021. Which consumer trends that emerged during lockdown are here to stay?
The Backlash
to Big Tech
Will a more tightly regulated digital economy continue to deliver growth and innovation? How will consumers benefit? And who should be the arbiter of free speech on the internet?